![](/img/cover-not-exists.png)
Gemcitabine, Oxaliplatin, and Paclitaxel (GOT) on a 2-Weekly Schedule in Patients (PTS) with Refractory Germ Cell Carcinoma: A Phase II Study Conducted at the University of Southern California
Quinn, D.I., Hamid, O., Tsao-Wei, D., Hu, J., Pinski, J., Schuckman, A., Daneshmand, S., Groshen, S., Raghavan, D., Korn, C., Massopust, K., Ketchens, C., Aparicio, A.M., Dorff, T.B.Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)33425-6
Date:
September, 2012
File:
PDF, 63 KB
2012